These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6510423)

  • 21. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.
    Goolden AW; Stewart JS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):217-22. PubMed ID: 3708873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism.
    Imseis RE; Vanmiddlesworth L; Massie JD; Bush AJ; Vanmiddlesworth NR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):685-7. PubMed ID: 9467593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.
    Horton PW; Millar WT; McLarty DG; Alexander WD
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):357-62. PubMed ID: 168992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of thyrotoxicosis with low doses of radioactive iodine.
    Goolden AW; Fraser TR
    Br Med J; 1969 Aug; 3(5668):442-3. PubMed ID: 5811653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases.
    Sugrue D; McEvoy M; Feely J; Drury MI
    Q J Med; 1980; 49(193):51-61. PubMed ID: 7433627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity of a thyroid nodule under the influence of stable iodide administration in a hyperthyroid patient.
    Nĕmec J; Vána S; Zamrazil V; Röhling S; Soumar J; Bednár J
    Nuklearmedizin; 1979; 18(6):293-6. PubMed ID: 537925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiobiological effects of 131I and 125I on the DNA of the rat thyroid. I. Comparative study with emphasis on the postradiation hypothyroidism occurrence.
    Abdel-Nabi H; Ortman JA
    Radiat Res; 1983 Mar; 93(3):525-33. PubMed ID: 6856755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol.
    Razvi S; Basu A; McIntyre EA; Wahid ST; Bartholomew PH; Weaver JU;
    Nucl Med Commun; 2004 Jul; 25(7):675-82. PubMed ID: 15208494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid stable iodine measurement in patients with hyperthyroidism.
    Kusić Z; Maisey M; Tang Fui N; Simonović I
    Acta Med Iugosl; 1985; 39(5):345-55. PubMed ID: 3832800
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term effects of anti-thyroid agents in thyrotoxicosis (author's transl)].
    Laroche C; Remy JM; Letellier P
    Ann Endocrinol (Paris); 1974; 35(1):67-8. PubMed ID: 4138459
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence.
    Barclay ML; Brownlie BE; Turner JG; Wells JE
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):759-64. PubMed ID: 8033366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function of thyroid and hypotalamic-pituitary-thyroid axis in radioiodine treated thyrotoxic patients.
    Helds A; Lerhs E; Bolshevica J; Ozols V
    Endokrinologie; 1980 Dec; 76(3):345-50. PubMed ID: 6781880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.
    Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of hypothyroidism after radioactive iodine therapy for thyrotoxicosis in Hong Kong Chinese.
    Best JD; Chan V; Khoo R; Teng CS; Wang C; Yeung RT
    Clin Radiol; 1981 Jan; 32(1):57-61. PubMed ID: 7214823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apathetic thyrotoxicosis.
    Arnold BM; Casal G; Higgins HP
    Can Med Assoc J; 1974 Nov; 111(9):957-8. PubMed ID: 4420812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyrotoxic periodic paralysis.
    Tran HA
    Endocr J; 2005 Oct; 52(5):651-2. PubMed ID: 16284448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.